Get started
CCC

CONTROL BIONICS LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

CBL chart


Full chart

CBL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪14.85 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.039 AUD
Net income (FY)
‪−5.91 M‬ AUD
Revenue (FY)
‪5.35 M‬ AUD
Shares float
—
Beta (1Y)
1.89

About CONTROL BIONICS LIMITED


Sector
Technology Services
Industry
Packaged Software
CEO
Jeremy E Steele
Website
controlbionics.com
Headquarters
Camberwell
Founded
2005
ISIN
AU0000114183
FIGI
BBG00Y540M48
Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. It operates through the following segments: Australia, US, International, R&D, and Corporate. The Australia segment is involved with the sales of Trilogy units and components in Australia. The US segment refers to Manufacture and sales of Trilogy units and components in North America. The International segment deals with the activities undertaken to establish viable and additional operating segments. The R&D segment pertains to the Research activities undertaken regarding the Group's products. The Corporate segment offers support, regulatory and infrastructure activities, and elimination entries above the EBITDA line. The company was founded by Peter Shann Ford in 2005 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

CBL news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CBL is 0.065 AUD — it has increased by 4.92% in the past 24 hours. Watch CONTROL BIONICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CONTROL BIONICS LIMITED stocks are traded under the ticker CBL.
CBL stock has risen by 3.23% compared to the previous week, the month change is a −14.67% fall, over the last year CONTROL BIONICS LIMITED has showed a 35.98% increase.
CBL reached its all-time high on Dec 8, 2020 with the price of 1.118 AUD, and its all-time low was 0.033 AUD and was reached on Dec 12, 2023. View more price dynamics on CBL chart.
See other stocks reaching their highest and lowest prices.
CBL stock is 6.56% volatile and has beta coefficient of 1.89. Track CONTROL BIONICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CONTROL BIONICS LIMITED there?
Today CONTROL BIONICS LIMITED has the market capitalization of ‪15.10 M‬, it has decreased by −4.69% over the last week.
Yes, you can track CONTROL BIONICS LIMITED financials in yearly and quarterly reports right on TradingView.
CONTROL BIONICS LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CBL net income for the last half-year is ‪−3.72 M‬ AUD, while the previous report showed ‪−2.19 M‬ AUD of net income which accounts for −70.01% change. Track more CONTROL BIONICS LIMITED financial stats to get the full picture.
No, CBL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONTROL BIONICS LIMITED EBITDA is ‪−6.02 M‬ AUD, and current EBITDA margin is −112.56%. See more stats in CONTROL BIONICS LIMITED financial statements.
Like other stocks, CBL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONTROL BIONICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONTROL BIONICS LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONTROL BIONICS LIMITED stock shows the buy signal. See more of CONTROL BIONICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.